Clinical Trial Update: Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study of a therapeutic HSV-2 vaccine by Genocea Biosciences completed, reporting safety and efficacy data in genital herpes due to HSV-2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• Therapeutic HSV-2 vaccine

Snippet

Sponsor: Genocea Biosciences, Inc. | Conditions: Genital Herpes Simplex Type 2 | Phase 2 | Status: COMPLETED